Thank you to everyone for such great comments, especially our authors, Dr. Dreyfuss and Dr. Gaudry. Our discussion continues through tomorrow evening, so continue to post any questions & comments you may have.
Drawing upon a conversation I had with Dr. Steed, a pediatric critical care fellow here at BJH/WUSM, and upon Dr. Dreyfuss' responses to the last thread, I wanted to ask everyone about your approaches to selecting a uniform study population.
In this study, a choice was made to enroll fairly ill patients (KDIGO 3) rather than the KDIGO 2 patients enrolled in the ELAIN trial. What was your rationale for this decision? Did you feel that this choice helped you address your questions, or did it make the study more difficult?
For all other visitors and experts, what has your experience been like selecting a study population? Is there anything you would have done differently? In this paper only about 11% of the screened patients with AKI underwent randomization. Have you found similar studies to have similar yields?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this challenge
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.